Key result
Early noncardiac surgery after coronary stenting and perioperative antiplatelet interruption increase the risk of major adverse cardiac events, primarily in-stent thrombosis.
Why the study?
How does the timing of noncardiac surgery, antiplatelet interruption, and prophylactic revascularization affect postoperative cardiac outcomes in patients with coronary stents?
How does the timing of noncardiac surgery, antiplatelet interruption, and prophylactic revascularization affect postoperative cardiac outcomes in patients with coronary stents?
In patients with coronary stents undergoing noncardiac surgery, early surgery and antiplatelet interruption increase the risk of adverse cardiac events, whereas prophylactic revascularization offers no benefit.
No takes yet. Share an insight, caveat, or question.
Supports caution with early noncardiac surgery and antiplatelet interruption after stenting; leaves open optimal timing and need for RCTs.
Schouten et al. (2007) conducted a review in Patients with cardiac stents undergoing noncardiac surgery. Early noncardiac surgery and antiplatelet therapy interruption was evaluated on Major adverse cardiac events and in-stent thrombosis. Early noncardiac surgery after coronary stenting and perioperative antiplatelet interruption increase the risk of major adverse cardiac events, primarily in-stent thrombosis.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: